U

    Utah Medical Products Inc (UTMD)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $71.13
    -1.64 (-2.25%)

    Market Cap: $226.47M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Jul 23
    		$0.84N/AN/ABeat-10.5%
    Mar 26
    Reported Apr 23
    		$0.82N/AN/ABeat-11.0%
    Dec 25
    Reported Jan 29
    		$0.80N/AN/ABeat-6.6%
    Sep 25
    Reported Oct 23
    		$0.82N/AN/ABeat-19.9%
    Jun 25
    Reported Jul 24
    		$0.94N/AN/ABeat-3.9%
    Mar 25
    Reported Apr 29
    		$0.92N/AN/ABeat-16.0%
    Dec 24
    Reported Mar 26
    		$0.86N/AN/ABeat-27.4%
    Sep 24
    Reported Oct 29
    		$1.02N/AN/ABeat-5.1%
    Jun 24
    Reported Jul 25
    		$0.98N/AN/ABeat-15.3%
    Mar 24
    Reported Apr 25
    		$1.09N/AN/ABeat-5.7%
    Dec 23
    Reported Mar 26
    		$1.18N/AN/ABeat-5.8%
    Sep 23
    Reported Oct 26
    		$1.08N/AN/ABeat-8.3%
    Jun 23
    Reported Jul 25
    		$1.15N/AN/ABeat+3.1%
    Mar 23
    Reported Apr 25
    		$1.16N/AN/ABeat+20.7%
    Dec 22
    Reported Mar 27
    		$1.25N/AN/ABeat+10.9%
    Sep 22
    Reported Oct 25
    		$1.18N/AN/ABeat+2.4%
    Jun 22
    Reported Jul 26
    		$1.12N/AN/ABeat+19.1%
    Mar 22
    Reported Apr 26
    		$0.96N/AN/ABeat+15.7%
    Dec 21
    Reported Mar 25
    		$1.13N/AN/ABeat-65.7%
    Sep 21
    Reported Oct 26
    		$1.15N/AN/ABeat+43.7%
    Jun 21
    Reported Jul 22
    		$0.94N/AN/ABeat+123.8%
    Mar 21
    Reported Apr 22
    		$0.83N/AN/ABeat-1.2%
    Dec 20
    Reported Mar 26
    		$3.29N/AN/ABeat+201.8%
    Sep 20
    Reported Oct 27
    		$0.80N/AN/ABeat-19.2%
    Jun 20
    Reported Jul 28
    		$0.42N/AN/ABeat-55.3%
    Mar 20
    Reported Apr 23
    		$0.84N/AN/ABeat+0.0%
    Dec 19
    Reported Mar 16
    		$1.09N/AN/ABeat+990.0%
    Sep 19
    Reported Oct 24
    		$0.99N/AN/ABeat-45.0%
    Jun 19
    Reported Jul 30
    		$0.94N/AN/ABeat-18.3%
    Mar 19
    Reported Apr 25
    		$0.84N/AN/ABeat-18.4%
    Dec 18
    Reported Mar 14
    		$0.10N/AN/ABeat-89.5%
    Sep 18
    Reported Oct 23
    		$1.80N/AN/ABeat+85.6%
    Jun 18
    Reported Jul 24
    		$1.15N/AN/ABeat+10.6%
    Mar 18
    Reported Apr 26
    		$1.03N/AN/ABeat+8.4%
    Dec 17
    Reported Jan 30
    		$0.95N/AN/ABeat+31.0%
    Sep 17
    Reported Oct 24
    		$0.97N/AN/ABeat+24.8%
    Jun 17
    Reported Jul 25
    		$1.04$0.00N/ABeat-
    Mar 17
    Reported Apr 25
    		$0.95$0.00N/ABeat-
    Dec 16
    Reported Mar 8
    		$0.72N/AN/ABeat-
    Sep 16
    Reported Nov 4
    		$0.78N/AN/ABeat-

    Dividends

    Dividend Metrics

    Yield1.74%
    Annual/Share$1.23
    Payout Ratio33.19%
    Frequency4
    Pay MonthsJan, Apr, Jul, Oct

    Growth

    3Y CAGR+1.69%
    5Y CAGR+1.72%
    View UTMD's full dividend history

    Key Metrics

    Valuation
    P/E Ratio21.70EV/EBITDA11.10x
    Price/FCF19.78xFCF Yield5.05%
    Profitability
    Profit Margin29.00%Operating Margin36.90%
    ROE8.76%ROIC8.58%
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio48.62xQuick Ratio44.27x
    Trading Statistics
    Beta0.36Avg Volume31.75K
    52-Week High$75.7552-Week Low$52.87

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$71.63
    SMA 20$71.46
    SMA 50$70.24
    SMA 200$64.21
    EMA 10$71.54
    EMA 20$71.26
    EMA 50$70.11
    EMA 200$65.57

    MACD

    Line: 0.45Signal: 0.53Hist: -0.08

    ADX

    ADX: 9.0+DI: 22.1-DI: 24.5

    Aroon & PSAR

    Aroon Up20.0
    Aroon DownN/A
    PSAR$70.22

    Bollinger Bands

    Upper Band$72.88
    Lower Band$70.05
    %B Position397%(Upper)
    Band Width0.38

    RSI (14-Day)

    Neutral
    50.5

    Momentum Oscillators

    Stoch %K57.8
    Stoch %D54.7
    Williams %R-62.5
    ROC (10d)1.3%
    Momentum0.92
    CCI (20d)25.3
    MFI (14d)40.6

    Volatility Measures

    ATR (14d)$2.02(2.8%)
    StdDev (20d)0.71
    Hist Vol19.5%(Low)

    Volume Flow

    VWAP$71.69
    OBV15.9K
    AD Line-3.9M
    CMF (20d)0.047

    Volume Metrics

    Avg Vol (20d)32.6K
    Vol Ratio1.0x
    VWMA (20d)$71.55

    Pivot Points

    R3$75.25
    R2$74.30
    R1$73.53
    Pivot Point$72.58
    S1$71.81
    S2$70.86
    S3$70.09

    Advanced Oscillators

    TSI6.64
    Ultimate Osc54.5
    KST21.38

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$8.53M$8.72M$9.04M$9.81M$9.95M$9.71M$9.16M$10.01M$10.40M$11.34M$12.33M$12.51M
    Cost of Revenue$3.77M$3.44M$4.31M$4.75M$4.36M$4.17M$3.84M$4.20M$4.15M$4.57M$5.24M$5.15M
    Gross Profit$4.76M$5.28M$4.73M$5.06M$5.59M$5.54M$5.32M$5.80M$6.25M$6.77M$7.10M$7.36M
    Operating Expenses$2.11M$2.72M$2.29M$2.45M$2.40M$2.38M$2.39M$2.46M$2.81M$2.88M$3.15M$3.39M
    R&D$154,000$154,000$212,000$167,000$135,000$154,000$120,000$172,000$255,000$266,000$145,000$138,000
    SG&A$1.96M$2.56M$2.61M$2.83M$2.26M$2.23M$371,000$2.29M$2.56M$2.62M$1.32M$3.25M
    Operating Income$2.65M$2.56M$2.44M$2.61M$3.20M$3.15M$2.93M$3.34M$3.44M$3.88M$3.94M$3.97M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$3.29M$3.18M$3.11M$3.31M$3.84M$3.86M$3.61M$4.18M$4.21M$4.80M$5.02M$4.78M
    Income Tax Expense$600,000$578,000$541,000$678,000$788,000$817,000$712,000$616,000$758,000$842,000$731,000$846,000
    Net Income$2.69M$2.60M$2.56M$2.63M$3.05M$3.04M$2.90M$3.56M$3.45M$3.96M$4.29M$3.94M
    EBITDA$3.53M$3.87M$3.85M$4.06M$4.59M$4.58M$962,000$4.92M$4.90M$5.48M$3.00M$6.57M
    EBIT$3.29M$3.18M$3.11M$3.31M$3.84M$3.86M$232,000$4.18M$4.21M$4.80M$1.96M$4.78M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about UTMD

    News

    Rice Hall James & Associates LLC Invests $4.92 Million in Utah Medical Products, Inc. $UTMD

    Rice Hall James & Associates LLC has acquired a new stake in Utah Medical Products, Inc. (NASDAQ:UTMD) by purchasing 71,363 shares valued at approximately $4.92 million, representing about 2.24% of the company. Other institutional investors have also adjusted their holdings, with 69.60% of the stock owned by hedge funds and institutions. Analysts currently hold a consensus "Hold" rating for UTMD, which recently reported quarterly earnings of $0.84 per share and declared a quarterly dividend of $0.31 per share.

    MarketBeat•8/18/26•
    Neutral

    Brandes Investment Partners reports 14.9% Utah Medical Products (UTMD) stake

    Brandes Investment Partners has filed an amended Schedule 13G, disclosing a 14.92% passive ownership stake in Utah Medical Products Inc., totaling 475,158 common shares. These shares are held across mutual funds and other accounts advised by Brandes, with the Brandes Small Cap Value Fund alone holding 6.87% of the class. The filing indicates shared voting power over 435,111 shares and shared dispositive power over all 475,158 shares, with no sole control reported.

    Stock Titan•8/14/26•
    Neutral

    Utah Medical Products (NASDAQ:UTMD) Shares Pass Above 200 Day Moving Average - Time to Sell?

    Utah Medical Products (NASDAQ:UTMD) shares have risen above their 200-day moving average, reaching $72.37 against an average of $66.51. The company reported quarterly earnings of $0.84 per share on $8.53 million in revenue and declared a $0.31 quarterly dividend, equivalent to a 1.7% annual yield. Analyst sentiment remains neutral, with a consensus "Hold" rating, despite a recent upgrade from Weiss Ratings.

    MarketBeat•8/14/26•
    Neutral

    Renaissance Technologies (UTMD) discloses 5.52% ownership in Utah Medical Products

    Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have reported a beneficial ownership of 175,814 shares, or 5.52%, in Utah Medical Products Inc. as of June 30, 2026. Both entities hold sole voting and dispositive power over these shares. The filing, a Schedule 13G/A, indicates that certain funds managed by Renaissance Technologies LLC are entitled to receive dividends and proceeds from the sale of these securities.

    Stock Titan•8/13/26•
    Neutral

    Trading Systems Reacting to (UTMD) Volatility

    This article analyzes the volatility of Utah Medical Products Inc. (NASDAQ: UTMD), highlighting a strong overweight bias across all sentiment horizons. It details three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, providing entry and exit points, targets, and stop losses. The analysis points to an exceptional 29.2:1 risk-reward setup for the stock.

    Stock Traders Daily•8/13/26•
    Bullish

    Frequently Asked Questions About UTMD

    What is UTMD's current dividend yield?
    Utah Medical Products Inc (UTMD) has a current dividend yield of 1.74%.
    Does UTMD pay dividends?
    Yes, Utah Medical Products Inc pays dividends with a current yield of 1.74%.
    What is UTMD's P/E ratio?
    Utah Medical Products Inc has a price-to-earnings (P/E) ratio of 21.70.
    What is UTMD's market cap?
    Utah Medical Products Inc (UTMD) has a market capitalization of $226.47M with a current stock price of $71.13.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In